Latest Public Health News

Page 5 of 5
TruScreen has launched a landmark five-year cervical cancer screening program in Ho Chi Minh City, targeting 260,000 women with its AI-driven, non-invasive technology to boost screening rates and support Vietnam’s national health goals.
Ada Torres
Ada Torres
22 Apr 2025
Smartgroup has been appointed as the exclusive provider of salary packaging and novated leasing services for Monash Health’s 25,000 employees under a new multi-year contract starting April 2025.
Ada Torres
Ada Torres
10 Feb 2025
Bio-Gene Technology Limited has secured A$3 million in U.S. Department of Defense grants to accelerate development of its two nature-derived insecticides, Flavocide and Qcide, targeting both military and civilian markets.
Ada Torres
Ada Torres
4 Feb 2025
Skin Elements Limited reports steady progress in commercialising its plant-based SE Formula biotechnology, highlighted by ongoing product trials, a successful R&D rebate, and a $513k non-renounceable entitlement issue.
Ada Torres
Ada Torres
31 Jan 2025
Advanced Health Intelligence Ltd has locked in a USD$4 million convertible note facility with UAE-based KOR Investments LLC, aiming to raise up to AUD$10 million to fuel its MENA expansion and reduce debt.
Ada Torres
Ada Torres
30 Jan 2025
Unith Ltd has reported its strongest quarterly revenue in two years, driven by its B2C subscription division and strategic partnerships, while advancing its Digital Human technology and expanding into new markets.
Sophie Babbage
Sophie Babbage
30 Jan 2025
Atomo Diagnostics reports a robust Q2 FY25 with $1.2 million revenue driven by HIV self-test sales and a significant $2.44 million government grant for syphilis test development. The company advances its market footprint in Australia and New Zealand while maintaining a strong cash position.
Ada Torres
Ada Torres
30 Jan 2025
Bio-Gene Technology Limited has advanced its bio-insecticide pipeline with two U.S. Department of Defense grants totaling A$3 million, alongside key regulatory and production milestones for Flavocide® and Qcide®.
Victor Sage
Victor Sage
30 Jan 2025
Bio-Gene Technology Limited has been awarded two U.S. Department of Defense grants totaling A$3 million to develop innovative insect control products targeting military and civilian markets.
Ada Torres
Ada Torres
29 Jan 2025
Recce Pharmaceuticals has successfully dosed all patients in its Phase II trial of RECCE® 327 topical gel for acute bacterial skin infections, showing encouraging preliminary efficacy and safety data. The company is preparing for pivotal Phase III trials in Australia and Indonesia, targeting a significant global market opportunity.
Victor Sage
Victor Sage
21 Jan 2025
Unith Ltd has strengthened its financial position through a partial divestment in AudioStack while renewing a key public health contract and achieving its highest B2C subscription revenue in two years.
Sophie Babbage
Sophie Babbage
13 Jan 2025